Efficacy and tolerance of gemcitabine-based regimens in elderly patients with advanced pancreatic cancer

被引：0
|
作者：
Marechal, Raphael
Demols, Anne
Gay, France
Arvanitakis, Marianna
Hendlisz, Alain
Van Laethem, Jean-Luc
机构：
[1] Erasme Univ Hosp, B-1070 Brussels, Belgium
[2] Inst Jules Bordet, B-1000 Brussels, Belgium
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：326 / 326
页数：1
相关论文
共 50 条
  • [1] Tolerance and efficacy of gemcitabine and gemcitabine-based regimens in elderly patients with advanced pancreatic cancer
    Marechal, Raphael
    Demols, Anne
    Gay, France
    de Maertelaer, Viviane
    Arvanitaki, Marianna
    Hendlisz, Alain
    Van Laethem, Jean-Luc
    PANCREAS, 2008, 36 (03) : E16 - E21
  • [2] On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancer
    McGinn, CJ
    Lawrence, TS
    Zalupski, MM
    CANCER, 2002, 95 (04) : 933 - 940
  • [3] Is skeletal muscle a predictor of toxicity in pancreatic cancer patients on gemcitabine-based chemotherapy regimens?
    Freckelton, J.
    Croagh, D.
    Holt, D. Q.
    Fox, A.
    Wong, R.
    Moore, G. T.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 58 - 58
  • [4] Efficacy of the combined chemotherapy regimens in elderly patients with advanced pancreatic cancer
    Manukyan, M.
    Bazin, I.
    Chikhareva, Y.
    Tryakin, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S82 - S82
  • [5] Gemcitabine in elderly patients with advanced pancreatic cancer
    Olivia Hentic
    Vinciane Rebours
    Philippe Lévy
    Philippe Ruszniewski
    Pascal Hammel
    Magaly Zappa
    Chantal Dreyer
    Eric Raymond
    World Journal of Gastroenterology, 2011, 17 (30) : 3497 - 3502
  • [6] Gemcitabine in elderly patients with advanced pancreatic cancer
    Hentic, Olivia
    Dreyer, Chantal
    Rebours, Vinciane
    Zappa, Magaly
    Levy, Philippe
    Raymond, Eric
    Ruszniewski, Philippe
    Hammel, Pascal
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (30) : 3497 - 3502
  • [7] Comorbidity, not age, is prognostic in patients with advanced pancreatic cancer receiving gemcitabine-based chemotherapy
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Sasahira, Naoki
    Tsujino, Takeshi
    Kogure, Hirofumi
    Yagioka, Hiroshi
    Yashima, Yoko
    Togawa, Osama
    Arizumi, Toshihiko
    Matsubara, Saburo
    Hirano, Kenji
    Tada, Minoru
    Omata, Masao
    Koike, Kazuhiko
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 78 (03) : 252 - 259
  • [8] Efficacy and tolerance of gemcitabine and nab-paclitaxel in elderly patients with advanced pancreatic ductal adenocarcinoma
    Pignon, Flore
    Turpin, Anthony
    Hentic, Olivia
    Coriat, Romain
    Salmon, Emma
    Baumgaertner, Isabelle
    Bertrand, Nicolas
    Levy, Philippe
    Rebours, Vinciane
    Hammel, Pascal
    de Mestier, Louis
    PANCREATOLOGY, 2021, 21 (06) : 1064 - 1070
  • [9] A prospective randomized trial on two gemcitabine-based regimens of chemotherapy for unresectable pancreatic cancer
    Popiela, T
    Kulig, J
    Sierzega, M
    Legutko, J
    GASTROENTEROLOGY, 2005, 128 (04) : A109 - A109
  • [10] Gemcitabine-based Concurrent Chemoradiotherapy Versus Chemotherapy Alone in Patients with Locally Advanced Pancreatic Cancer
    Wang, Bu-Hai
    Cao, Wen-Miao
    Yu, Jie
    Wang, Xiao-Lei
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (05) : 2129 - 2132
12345